Societe De Therapeutique Marocaine operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Societe De Therapeutique Marocaine with three other
pharmaceutical manufacturers in Africa:
Glaxo Smithkline Consumer Nigeria PLC
sales of 18.41 billion Naira [US$60.02 million]
of which 65%
(444.53 million Moroccan Dirhams [US$46.27 million]
Fidson Healthcare Limited
based in Nigeria
(16.23 billion Naira [US$52.91 million]
Societe De Therapeutique Marocaine reported sales of 1.59 billion Moroccan Dirhams (US$165.57 million)
December of 2018.
increase of 12.4%
versus 2017, when the company's sales were 1.42 billion Moroccan Dirhams.
Sales at Societe De Therapeutique Marocaine have increased during each of the previous five years
(and since 2013, sales have increased a total of 42%).